Evidence map›Paper›PMID 42221110›Full record

ArticleFrontiers in medicine2026

Multimodal interventional bronchoscopy for chronic pulmonary

Wenjie Wu, Huaxu Yin, Xing Chen, Yanxia He, Bing Xue, Jie Zhang, Ting Wang

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wenjie WuDepartment of Respiratory and Critical Care Medicine, Chuiyangliu Hospital Affiliated to Tsinghua University, Beijing, China.
Huaxu YinDepartment of Respiratory and Critical Care Medicine, Chuiyangliu Hospital Affiliated to Tsinghua University, Beijing, China.
Xing ChenDepartment of Respiratory and Critical Care Medicine, Chuiyangliu Hospital Affiliated to Tsinghua University, Beijing, China.
Yanxia HeDepartment of Respiratory and Critical Care Medicine, Chuiyangliu Hospital Affiliated to Tsinghua University, Beijing, China.
Bing XueDepartment of Respiratory and Critical Care Medicine, Chuiyangliu Hospital Affiliated to Tsinghua University, Beijing, China.
Jie ZhangDepartment of Respiratory and Critical Care Medicine, Chuiyangliu Hospital Affiliated to Tsinghua University, Beijing, China.
Ting WangDepartment of Respiratory and Critical Care Medicine, Chuiyangliu Hospital Affiliated to Tsinghua University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic pulmonary aspergillosis (CPA) is an increasingly recognized complication of both active and treated pulmonary tuberculosis (PTB). Optimal treatment for CPA in PTB patients has not been established. Here, we report a 36-years-old female with a history of childhood pulmonary tuberculosis presenting with persistent low-grade fever after COVID-19 infection. Imaging showed right upper lobe consolidation and bronchial occlusion. Laboratory investigations revealed positive bronchoalveolar lavage fluid (BALF) and serum galactomannan, and microbiological analyses including targeted Next-Generation Sequencing (tNGS) identified

Indexed as

chronic pulmonary aspergillosiscryotherapyEBUS-TBNAinterventional bronchoscopypulmonary tuberculosis

Identifiers

PMID42221110
PMCPMC13219025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.